AB Science SA
1.5480
31-January-25 09:50:33
15 minutes delayed
Stocks
-0.0820
-5.03%
Today's range
1.5480 - 1.6240
ISIN
FR0010557264
Source
Cboe
-
14 Sep 2021 11:01:33 By Nasdaq GlobeNewswire
-
13 Sep 2021 11:04:50 By Nasdaq GlobeNewswire
-
02 Sep 2021 10:59:01 By Nasdaq GlobeNewswire
-
25 Aug 2021 11:46:55 By Nasdaq GlobeNewswire
-
23 Aug 2021 12:43:09 By Nasdaq GlobeNewswire
-
19 Aug 2021 10:51:36 By Nasdaq GlobeNewswire
-
06 Aug 2021 12:02:25 By Nasdaq GlobeNewswire
-
29 Jul 2021 11:06:56 By Nasdaq GlobeNewswire
-
19 Jul 2021 11:12:44 By Nasdaq GlobeNewswire
-
12 Jul 2021 01:00:28 By Nasdaq GlobeNewswire
-
28 Jun 2021 12:59:14 By Nasdaq GlobeNewswire
-
10 Jun 2021 11:54:29 By Nasdaq GlobeNewswire
-
08 Jun 2021 01:30:40 By Nasdaq GlobeNewswire
-
02 Jun 2021 08:32:44 By Nasdaq GlobeNewswire
-
AB Science announces a voluntary hold in the clinical studies of masitinib worldwide
31 May 2021 23:59:55 By Nasdaq GlobeNewswire
-
AB Science communicates results from Phase 3 study evaluating masitinib in prostate cancer
26 May 2021 12:18:48 By Nasdaq GlobeNewswire
-
AB Science will host a live webcast on Tuesday May 25, 2021 on masitinib results in Prostate Cancer
21 May 2021 11:01:41 By Nasdaq GlobeNewswire
-
20 May 2021 11:06:59 By Nasdaq GlobeNewswire